Analysis of the Complicated Nonlinear Pharmacokinetics of Orally Administered Telmisartan in Rats Using a Stable Isotope-IV Method

J Pharm Sci. 2019 Aug;108(8):2774-2780. doi: 10.1016/j.xphs.2019.03.023. Epub 2019 Mar 26.

Abstract

This study aimed to kinetically analyze the nonlinear absorption and systemic exposure of telmisartan (TEL) after oral administration to rats by using a stable isotope-IV method. Rats were orally administered different dose of TEL, followed by the intravenous injection of 0.005 mg/kg of deuterium-labeled TEL (TEL-d3). Assuming that TEL-d3 shows same pharmacokinetic properties with TEL, systemic clearance (CLtot), oral bioavailability (Foral), and intestinal and hepatic availability (Fa*Fg, Fh) of TEL were calculated in each individual rat. AUCpo of TEL increased disproportionately with dose and showed a sigmoid-type relation, indicating the involvement of multi-nonlinear processes in oral absorption of TEL. Fa*Fg of TEL increased with dose at the low-dose range while decreased at the high-dose range. In contrast, Fh increased and CLtot decreased significantly in the middle range (2 to 6 mg/kg). As main factors of nonlinearity, saturations of solubility, efflux transport in the intestine, and the hepatic uptake of TEL were indicated. In conclusion, this study demonstrated a high possibility of a stable isotope-IV method to characterize complicated pharmacokinetic properties of oral drugs in animals, which can help to consider the future risks in their clinical use.

Keywords: hepatic clearance; intestinal transporter; nonlinear pharmacokinetics; oral absorption; solubility.

MeSH terms

  • Administration, Oral
  • Angiotensin II Type 1 Receptor Blockers / administration & dosage
  • Angiotensin II Type 1 Receptor Blockers / pharmacokinetics*
  • Animals
  • Biological Availability
  • Deuterium / administration & dosage
  • Deuterium / pharmacokinetics
  • Intestinal Absorption
  • Kinetics
  • Liver / metabolism
  • Male
  • Nonlinear Dynamics
  • Rats
  • Rats, Sprague-Dawley
  • Telmisartan / administration & dosage
  • Telmisartan / pharmacokinetics*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Deuterium
  • Telmisartan